Does EZETIMIBE Cause Interstitial lung disease? 108 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Interstitial lung disease have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.8% of all adverse event reports for EZETIMIBE.
108
Reports of Interstitial lung disease with EZETIMIBE
0.8%
of all EZETIMIBE reports
10
Deaths
57
Hospitalizations
How Dangerous Is Interstitial lung disease From EZETIMIBE?
Of the 108 reports, 10 (9.3%) resulted in death, 57 (52.8%) required hospitalization, and 12 (11.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for EZETIMIBE.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which EZETIMIBE Alternatives Have Lower Interstitial lung disease Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI